Abbott Labs’ surprise guidance bump is a major positive for its shareholders

An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Articles You May Like

Frontier Airlines CEO urges crackdown of ‘rampant abuse’ of airport wheelchair service
We maintain our rating on Ford shares after a bullish Street initiation
Macy’s beats earnings estimates, as turnaround plan shows early progress
Nvidia crushes sky-high expectations and charts continued AI-driven dominance for years to come
Lowe’s beats on earnings and revenue, even as consumers spend less on DIY projects

Leave a Reply

Your email address will not be published. Required fields are marked *